Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma.
Rischin D, Porceddu S, Day F, Brungs DP, Christie H, Jackson JE, Stein BN, Su YB, Ladwa R, Adams G, Bowyer SE, Otty Z, Yamazaki N, Bossi P, Challapalli A, Hauschild A, Lim AM, Patel VA, Walker JL, De Liz Vassen Schurmann M, Queirolo P, Cañueto J, Ferreira da Silva FA, Stratigos A, Guminski A, Lin C, Damian F, Flatz L, Taylor AE, Carr DR, Harris S, Kirtbaya D, Quereux G, Rutkowski P, Basset-Seguin N, Khushalani NI, Robert C, Ju H, Joseph C, Bansal S, Chen CI, Seebach F, Yoo SY, Lowy I, Goncalves P, Fury MG; C-POST Trial Investigators. Rischin D, et al. Among authors: carr dr. N Engl J Med. 2025 May 31. doi: 10.1056/NEJMoa2502449. Online ahead of print. N Engl J Med. 2025. PMID: 40454639
Identifying the impact of minor risk factors in Brigham and Women's Hospital stage T1 cutaneous squamous cell carcinomas on risk of poor outcomes: A retrospective cohort study.
Shahwan KT, Walker TD, Tan A, Ruiz E, Ran N, Granger EE, Koyfman S, Vidimos A, Wysong A, Hirotsu KE, Carucci JA, Carter JB, Cañueto J, Girardi FM, Mangold AR, Srivastava D, Brodland DG, Zitelli JA, Willenbrink TJ, Carr DR. Shahwan KT, et al. Among authors: carr dr. J Am Acad Dermatol. 2025 Jun;92(6):1319-1326. doi: 10.1016/j.jaad.2025.02.052. Epub 2025 Feb 24. J Am Acad Dermatol. 2025. PMID: 40010504
Registries and Research Pertaining to Rare Cutaneous Tumors.
Mafee M, Yi MD, Carr DR, Alam M. Mafee M, et al. Among authors: carr dr. Dermatol Surg. 2024 Jun 1;50(6):581-582. doi: 10.1097/DSS.0000000000004130. Epub 2024 Feb 23. Dermatol Surg. 2024. PMID: 38394458 No abstract available.
Grading differentiation in cutaneous squamous cell carcinoma: A modified Delphi consensus panel.
Shahwan KT, Walker TD, Diede C, Nikahd M, Aasi SZ, Bordeaux JS, Christensen SR, Chung C, Elston DM, Grant-Kels JM, Ko CJ, Leitenberger JJ, Miller DD, Piliang M, Robinson-Bostom L, Ruiz ES, Tarbox M, Vidimos A, Carr DR. Shahwan KT, et al. Among authors: carr dr. J Am Acad Dermatol. 2025 May 8:S0190-9622(25)00706-6. doi: 10.1016/j.jaad.2025.05.003. Online ahead of print. J Am Acad Dermatol. 2025. PMID: 40345540 No abstract available.
Lymphovascular invasion is an independent predictor of metastasis and disease-specific death in cutaneous squamous cell carcinoma: A multicenter retrospective study.
Hirotsu KE, Aasi SZ, Samson KK, Zheng C, Nazaroff JR, Voller LM, Ruiz ES, Ran NA, Granger EE, Koyfman SA, Vidimos AT, Carr DR, Shahwan KT, Carucci JA, Carter JB, Cañueto J, Girardi FM, Mangold AR, Srivastava D, Brodland DG, Zitelli JA, Willenbrink TJ, Wysong A. Hirotsu KE, et al. Among authors: carr dr. J Am Acad Dermatol. 2025 Apr 17:S0190-9622(25)00623-1. doi: 10.1016/j.jaad.2025.04.029. Online ahead of print. J Am Acad Dermatol. 2025. PMID: 40253009
97 results